Suspected inflammatory bowel disease - The clinical and economic impact of competing diagnostic strategies

American Journal of Gastroenterology

Volumn 97, Issue 9, 2002, Pages 2333-2342

  Dubinsky, Marla C ^a   Johanson, John F ^b   Seidman, Ernest G ^c   Ofman, Joshua J ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d Zynx Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPARATIVE STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; ENTERITIS; HEALTH ECONOMICS; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SCREENING TEST; SERODIAGNOSIS;

EID: 0036734312     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2002.05988.x     Document Type: Article

References (28)

1. Classification of inflammatory bowel disease
2. Criteria of case definition in Crohn's disease and ulcerative colitis
3. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease
4. Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease
5. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease: Is IgA antibody a marker for Crohn's disease?
6. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance
7. Specific antibody response to oligomannosidic epitopes in Crohn's disease
8. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role
9. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses
10. Anti-neutrophil cytoplasmic antibodies in children with ulcerative colitis
11. Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis
12. Antineutrophil cytoplasmic antibodies in children with inflammatory bowel disease: Prevalence and diagnostic value
13. Prospective evaluation of neutrophil autoantibodies in 500 consecutive patients with inflammatory bowel disease
14. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
15. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type I autoimmune hepatitis, and primary sclerosing cholangitis
16. Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease
17. Serologic testing for inflammatory bowel disease
18. Utility of perinuclear anti-neutrophil cytoplasmic antibodies (pANCA), anti-Saccharomyces Cerevisiae (ASCA), and anti-pancreatic antibodies (APA) as serologic markers in a population based cohort of patients with Crohn's disease (CD) and ulcerative colitis (UC)
19. Clinical evaluation of a new immunodiagnostic assay system for inflammatory bowel disease
20. Clinical utility of sero-diagnostic testing in suspected pediatric IBD
21. Irritable bowel syndrome: Guidelines for the diagnosis
22. Costs of care for irritable bowel syndrome patients in a health maintenance organization
23. Colonoscopy in inflammatory bowel disease. Diagnostic accuracy and proposal of an endoscopic score
24. Comparison of indium-111 scintigraphy and colonoscopy with histologic study in children for evaluation of colonic chronic inflammatory bowel disease
25. Crohn's disease of the small intestine: Accuracy and relevance of enteroclysis
26. Differentiation of inflammatory bowel conditions by endoscopy and biopsy
27. Conflicting results of ileoscopy and small bowel double-contrast barium examination in patients with Crohn's disease